R.W. Watkins

544 total citations
16 papers, 376 citations indexed

About

R.W. Watkins is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Biochemistry. According to data from OpenAlex, R.W. Watkins has authored 16 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 4 papers in Biochemistry. Recurrent topics in R.W. Watkins's work include Heart Failure Treatment and Management (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). R.W. Watkins is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). R.W. Watkins collaborates with scholars based in United States, United Kingdom and Mexico. R.W. Watkins's co-authors include Edmund J. Sybertz, Subbarao Vemulapalli, Martin F. Haslanger, Peter J.S. Chiu, Kathryn Pula, Thomas Baum, Carolyn Foster, A Barnett, Barry J.R. Pitts and Maria A. Rivelli and has published in prestigious journals such as Hypertension, Journal of Pharmacology and Experimental Therapeutics and Cellular and Molecular Life Sciences.

In The Last Decade

R.W. Watkins

16 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.W. Watkins United States 8 132 96 85 63 63 16 376
May C.M. Yang Taiwan 15 51 0.4× 71 0.7× 196 2.3× 50 0.8× 75 1.2× 32 573
Koichi Seta Japan 9 193 1.5× 56 0.6× 396 4.7× 71 1.1× 35 0.6× 32 616
Maryse Crabos France 13 312 2.4× 44 0.5× 353 4.2× 72 1.1× 121 1.9× 24 653
H.‐J. Mest Germany 12 152 1.2× 64 0.7× 138 1.6× 68 1.1× 173 2.7× 61 559
Shin-ichiro Ashida Japan 14 202 1.5× 15 0.2× 121 1.4× 49 0.8× 60 1.0× 27 606
Guy Bompart France 11 77 0.6× 22 0.2× 145 1.7× 38 0.6× 20 0.3× 29 423
尚三 山本 3 46 0.3× 33 0.3× 143 1.7× 38 0.6× 24 0.4× 3 555
Ariel H. Polizio Argentina 14 147 1.1× 37 0.4× 354 4.2× 25 0.4× 73 1.2× 33 772
Delores J. Blehm United States 11 190 1.4× 21 0.2× 94 1.1× 24 0.4× 82 1.3× 12 357
Kumiko Ohta Japan 14 83 0.6× 60 0.6× 203 2.4× 9 0.1× 32 0.5× 21 413

Countries citing papers authored by R.W. Watkins

Since Specialization
Citations

This map shows the geographic impact of R.W. Watkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.W. Watkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.W. Watkins more than expected).

Fields of papers citing papers by R.W. Watkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.W. Watkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.W. Watkins. The network helps show where R.W. Watkins may publish in the future.

Co-authorship network of co-authors of R.W. Watkins

This figure shows the co-authorship network connecting the top 25 collaborators of R.W. Watkins. A scholar is included among the top collaborators of R.W. Watkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.W. Watkins. R.W. Watkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Grange, Linda La, et al.. (1999). Protective effects of the flavonoid mixture, silymarin, on fetal rat brain and liver. Journal of Ethnopharmacology. 65(1). 53–61. 62 indexed citations
2.
Tian, Zhenyu, et al.. (1995). Determination of a cyclic guanine monophosphate phosphodiesterase inhibitor (SCH 51866) in rat serum using capillary zone electrophoresis. Journal of Chromatography B Biomedical Sciences and Applications. 669(1). 141–148. 4 indexed citations
3.
Davis, Harry R., R.W. Watkins, Brian Salisbury, et al.. (1994). Effect of the cholesterol absorption inhibitor SCH48461 in combination with the HMG-CoA reductase inhibitor lovastatin in rabbits, dogs and rhesus monkeys. Atherosclerosis. 109(1-2). 162–163. 9 indexed citations
4.
Watkins, R.W., Subbarao Vemulapalli, Peter J.S. Chiu, et al.. (1993). Atrial Natriuretic Factor Potentiating and Hemodynamic Effects of SCH 42495, a New, Neutral Metalloendopeptidase Inhibitor. American Journal of Hypertension. 6(5_Pt_1). 357–368. 7 indexed citations
5.
McMullan, Geoff, R.W. Watkins, David B. Harper, & John P. Quinn. (1991). Carbon-phosphorus bond cleavage activity in cell-free extracts of Enterobacter aerogenes ATCC 15038 and Pseudomonas sp. 4ASW.. PubMed. 25(2). 271–9. 13 indexed citations
6.
Watkins, R.W., et al.. (1990). Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.. PubMed. 302. 158–73. 1 indexed citations
7.
Sybertz, Edmund J., P. J. S. Chiu, R.W. Watkins, & Subbarao Vemulapalli. (1990). Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.. PubMed. 8(7). S161–7. 14 indexed citations
8.
Sybertz, Edmund J., Peter J.S. Chiu, Subbarao Vemulapalli, R.W. Watkins, & Martin F. Haslanger. (1990). Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.. Hypertension. 15(2). 152–161. 51 indexed citations
9.
Sybertz, Edmund J., Peter J.S. Chiu, Subbarao Vemulapalli, et al.. (1989). SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 250(2). 624–631. 93 indexed citations
10.
Sybertz, Edmund J., R.W. Watkins, Thomas Baum, Kathryn Pula, & Maria A. Rivelli. (1985). Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.. Journal of Pharmacology and Experimental Therapeutics. 232(1). 156–162. 49 indexed citations
11.
Nagasubramanian, S., et al.. (1982). Addition of pindolol to routine medical therapy: a clinical trial.. British Journal of Ophthalmology. 66(2). 102–108. 5 indexed citations
12.
Baum, Thomas, R.W. Watkins, Edmund J. Sybertz, et al.. (1981). Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.. Journal of Pharmacology and Experimental Therapeutics. 218(2). 444–452. 50 indexed citations
13.
Watkins, R.W. & I. W. F. Davidson. (1980). Effects of competitive antagonists on phasic and tonic components of vascular smooth muscle contraction.. PubMed. 244(2). 200–10. 4 indexed citations
14.
Watkins, R.W. & I. W. F. Davidson. (1980). Action of histamine on phasic and tonic components of vascular smooth muscle contraction. Cellular and Molecular Life Sciences. 36(5). 582–584. 7 indexed citations
15.
Nagasubramanian, S., J. Gloster, D Poinoosawmy, & R.W. Watkins. (1980). A long term study of low concentration guanethidine and adrenaline therapy in glaucoma. International Ophthalmology. 3(1). 19–23. 2 indexed citations
16.
Nagasubramanian, S., et al.. (1980). Addition of timolol maleate to routine medical therapy: a clinical trial.. British Journal of Ophthalmology. 64(10). 779–781. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026